Work

Correction: Nishikubo et al. FGFR2 Might Be a Promising Therapeutic Target for Some Solid Tumors: Analysis of 1312 Cancers with FGFR2 Abnormalities. Int. J. Mol. Sci. 2025, 26, 10777

Year: 2026

Type: erratum

Abstract: In the original publication [...].

Source: International Journal of Molecular Sciences

DOI: 10.3390/ijms27020665

Authors: Hinano Nishikubo, Dongheng Ma, Tomoya Sano, Daiki Imanishi, Takashi Sakuma, Canfeng Fan, Yurie Yamamoto, Motohiro Yamamori, Masakazu Yashiro

Institutions: Osaka Metropolitan University, Mukogawa Women's University

Language: English

Topic: Fibroblast Growth Factor Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,499

Funder: Japan Society for the Promotion of Science

Awards: G2135868886, G2480357066, Development of companion tools for CXCL1 signaling target therapy against CAF in scirrhous gastric carcinoma, G647746995

OpenAlex ID: W7119527138

Cites: 1

Cited by:

Related to: